Data as of Jan 30
| +0.12 / +1.66%|
The 3 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 13.00, with a high estimate of 19.00 and a low estimate of 12.00. The median estimate represents a +76.63% increase from the last price of 7.36.
The current consensus among 3 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.